99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057 ) CAS 1187431-43-1

Model NO.
1187431-43-1
Delivery Detail
Prompt
Package
Aluminum Foil Bag
Transport Package
as Per Your Requirement
Specification
GMP
Trademark
Mesochem
Origin
China
HS Code
2934999090
Production Capacity
500kg Per Month
Reference Price
Please contact us for quote
Contact Us

Product Description

C ertificate    of   A nalysis
Product Name:  Trametinib dimethyl sulfoxide
CAS:  1187431-43-1
B atch  N o . HF1 60822 Q uantity 1240 kgs
Mfg. Date Aug . 22 , 201 6 Package As required
R ep . D ate Aug . 25 , 201 6 E xp . D ate Aug . 21 , 201 8
I tems S tandards R esults
Appearance White or off-white   powder Off- white powder
I dentification By HPLC Complies
Melting Point 120 ºC ~ 130 ºC 126 ºC
Loss on Drying ≤ 1.00 % 0. 21 %
H eavy  M etal s ≤   1 0ppm Complies
Sulfated Ash ≤   0. 10 % 0.0 3 %
  C ontent 17.5% ~ 19.5% 19.3%
Arsenic Content ≤   0.1 ppm 0.09ppm
Lead VContent ≤   3.0 ppm 0.50ppm
Content ≤   0.1 ppm 0.10ppm
Content ≤   0.1 ppm 0.10ppm
Microbiological Test Coliforms : Negative Negative
Salmonella : Negative Complies
Total plate count : ≤ 10 00  CFU/ g Pass
Yeast&Mold: ≤ 50  CFU/ g Pass
R elated  S ubstances Impurity A: ≤ 0.30% 0. 18 %
Other unknown  impurity : ≤ 0.10% 0.07%
Total Impurities : ≤ 0.50% 0.4 2 %
A ssay ≥  98.0% 99. 5 0%
Reference Standard USP  Standard
Conclusion The product  complie d  to   USP  standard .
Storage Preserve in tight,light-resistant containers in a cool place
99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1 99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1 99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1 99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1 99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1 99% Assay Trametinib Pharmaceutical Powder (GSK1120232, JTP 74057) CAS 1187431-43-1

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023